Alyeska Investment Group, L.P.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1453072 CHICAGO, IL

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,189,203

+$8,935,886 QoQ

Shares Held

1,328,449

+557.2% QoQ

Ownership

1.74%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,189,203	1,328,449	+557.2%	Shares	Sole	2026-05-15
2024-06-30	$1,253,317	202,148	0.0%	Shares	Sole	2024-08-14
2024-03-31	$1,908,277	202,148	0.0%	Shares	Sole	2024-05-15
2023-12-31	$1,364,499	202,148	0.0%	Shares	Sole	2024-02-14
2023-09-30	$897,537	202,148	0.0%	Shares	Sole	2023-11-14
2023-06-30	$667,088	202,148	+32.9%	Shares	Sole	2023-08-14
2023-03-31	$433,621	152,148	-66.4%	Shares	Sole	2023-05-15
2020-12-31	$5,302,252	452,797	+116.9%	Shares	Sole	2021-02-16
2020-09-30	$1,655,443	208,757	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.